78 research outputs found
Inferior Vena Caval Thrombosis After Traumatic Liver Injury
We report here the case of a 35-year-old man who
presented with inferior vena cava thrombosis
(IVCT) after blunt hepatic trauma. The IVCT was
incidentally detected by computed tomography (CT)
35 days after deep parenchymal suturing and suture
approximation for liver lacerations. The patient
denied any symptoms of thrombophlebitis. However,
he had presented with significantly elevated
values of FDP-D-dimer and a modest increase in
plasminogen concentration, which indicated that he
had been in a hypercoagulable and hypofibrinolytic
state after the operation. He had not undergone any
prophylactic anticoagulant therapy because of his
concomitant subarachnoid hemorrhage and huge
hepatic hematoma. The patient was treated with an
emercy thrombectomy. Posttraumatic IVCT is extremely
rare phenomenon. We should consider IVCT
in patients with a severe hepatic injury, particularly
if their coagulation system change into hypercoagulable
and hypofibrinolytic state. Additionally, this
case made us reflect on the treatment of traumatic
liver injury
Possible Protective Effect of Remote Ischemic Preconditioning on Acute Kidney Injury Following Elective Percutaneous Coronary Intervention: Secondary Analysis of a Multicenter, Randomized Study
Remote ischemic preconditioning (RIPC) is a promising strategy for protecting against ischemic reperfusion injury. This study is a secondary analysis of a randomized study that aimed to evaluate the effect of RIPC on the early increase in serum creatinine (SCr) following percutaneous coronary intervention (PCI), which is associ-ated with contrast-induced acute kidney injury. Patients with stable angina undergoing elective PCI were assigned to control, RIPC, and continuous infusion of nicorandil (nicorandil) groups. The endpoint of this study was the incidence of the early increase in SCr, a predictor of contrast-induced acute kidney injury, which was defined as either a > 20% or absolute increase by 0.3 mg/dl of SCr levels after 24 h of PCI. This study included 220 patients for whom a dataset of SCr values was available. The incidence of the early increase in SCr was significantly lower in the RIPC than in the control (1.3% vs 10.8%, p = 0.03) group, but was not significantly different between the nicorandil and control groups. In multivariate analysis, RIPC remained a significant fac-tor associated with a reduction in the incidence of early increase in SCr. RIPC reduces the incidence of early increase in SCr in patients with stable angina following elective PCI
Repeated Hepatic Dearterialization for Unresectable Liver Metastases From Gastric Cancer: Review of Five Cases
A novel method of repeated hepatic dearterialization was evaluated in five patients with multiple
metastases from gastric cancer in both hepatic lobes. After gastrectomy with extensive lymph node
dissection (R2/3), all patients underwent implantation of a vascular occluder around the hepatic
artery. Cannulation of the hepatic artery was added for later chemotherapy. The hepatic artery was
occluded repeatedly for 1 hour twice daily in combination with intrahepatic infusion of anticancer
drugs for as long as possible. Three of five patients demonstrated marked tumour regression with
unexpectedly long survival (16 months in two patients and one still alive at 15 months).
Carcinoembryonic antigen (CEA) levels decreased to almost normal in four patients who had initially
high levels. The present experiences seems to indicate that long survival can be hoped for in patients
with advanced gastric cancer with unresectable liver metastases
Detection of Strong Millimeter Emission from the Circumstellar Dust Disk Around V1094 Sco: Cold and Massive Disk around a T Tauri Star in a Quiescent Accretion Phase?
We present the discovery of a cold massive dust disk around the T Tauri star
V1094 Sco in the Lupus molecular cloud from the 1.1 millimeter continuum
observations with AzTEC on ASTE. A compact (320 AU) continuum
emission coincides with the stellar position having a flux density of 272 mJy
which is largest among T Tauri stars in Lupus. We also present the detection of
molecular gas associated with the star in the five-point observations in
CO J=3--2 and CO J=3--2. Since our CO and CO
observations did not show any signature of a large-scale outflow or a massive
envelope, the compact dust emission is likely to come from a disk around the
star. The observed SED of V1094 Sco shows no distinct turnover from near
infrared to millimeter wavelengths, which can be well described by a flattened
disk for the dust component, and no clear dip feature around 10 \micron
suggestive of absence of an inner hole in the disk. We fit a simple power-law
disk model to the observed SED. The estimated disk mass ranges from 0.03 to
0.12 M_\sun, which is one or two orders of magnitude larger than the
median disk mass of T Tauri stars in Taurus.Comment: 18 pages, 4 figures, accepted for publication in Ap
Non-drug and surgical treatment algorithm and recommendations for the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis—secondary publication
[Objectives] The aim of this study was to update the Japan College of Rheumatology (JCR) clinical practice guidelines (CPGs) for the management of rheumatoid arthritis (RA) and prepare an algorithm for non-drug and surgical treatments. This article is a digest version of the guidelines. [Methods] The Japanese Ministry of Health, Labour and Welfare’s research group, in collaboration with the JCR, used the Grading of Recommendations, Assessment, Development, and Evaluation method to update the 2014 JCR CPG for RA. The consensus was formed by CPG panel members. [Results] We raised 19 clinical questions regarding non-drug and surgical treatments for RA and developed recommendations. The treatments included exercise therapy; occupational therapy; joint injection of corticosteroids; and orthopaedic surgeries including cervical spine surgery, wrist and foot arthroplasty, ankle arthrodesis, and replacement arthroplasty of the shoulder, elbow, finger, hip, knee, and ankle. Recommendations regarding the risks of surgery and perioperative discontinuation of medications have also been developed. Based on these recommendations, we created an original algorithm for the non-drug and surgical treatment of RA. [Conclusions] These recommendations are expected to serve rheumatologists, health care professionals, and patients with RA as tools for shared decision-making to treat residual limb joint symptoms and functional impairment
Infectious cerebral thromboembolism in a patient with lung cancer during long-term administration of gefitinib: a case report
Introduction Gefitinib is a molecularly targeted drug for oral administration, a selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). It is effective for patients with lung cancer who have EGFR mutation and enables long-term survival of patients with advanced disease.Case presentation An 84-year-old Asian female with lung cancer (adenocarcinoma, cT4N3M1b stage IV PUL BRA OSS ADR) was treated by gefitinib for two years. The primary tumor was markedly reduced, and bone metastasis had almost disappeared. However, the patient became unconsciousness with general edema and died two days after falling unconsciousness. In the autopsy, it was diagnosed as infectious cerebral thromboembolism due to infectious endocarditis. The cause of death was cardiac tamponade.Conclusions While long-term survival can be expected in patients with advanced lung cancer by molecular-targeted agents, cautious management is warranted for complications, the same as for the primary disease
Plasma Thrombopoietin Levels are Unlikely to Account for the Platelet-sparing Effect of Paclitaxel in Lung Cancer Patients
Purpose: The present study was designed to determine whether the combination of carboplatin (CBDCA) with paclitaxel (PTX) spared CBDCA-induced thrombocytopenia by increased plasma thrombopoietin (TPO) levels. Methods: Patients with non-small-cell and small-cell lung cancer were consecutively assigned to CBDCA with PTX regimen (CBDCA/PTX) and CBDCA with irinotecan (CPT-11) regimen (CBDCA/CPT-11), respectively. Results: Ten patients were entered into either CBDCA/PTX (n=5) or CBDCA/CPT-11 (n=5). CBDCA/PTX showed a lesser reduction of platelet counts than CBDCA/CPT-11 (p<0.05), although more severe neutropenia was observed in CBDCA/PTX (p<0.01). The plasma TPO levels were inversely correlated with circulating platelet counts in CBDCA/PTX and CBDCA/CPT-11. However, the increased rate of plasma TPO levels in CBDCA/PTX was not significantly different from that in CBDCA/CPT-11. Conclusions: These findings suggest that the increased plasma TPO levels in CBDCA/PTX result secondarily from thrombocytopenia, and that circulating TPO is probably not involved in the platelet-sparing effect of PTX
Naturally absorbed lithium may prevent suicide attempts and deliberate self-harm while eicosapentaenoic acid may prevent deliberate self-harm and arachidonic acid may be a risk factor for deliberate self-harm: The updated different findings in new analyses
BackgroundSince our previous investigation on the effects of trace lithium, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and arachidonic acid (AA) on deliberate self-harm and suicide attempts in 2018, to our knowledge, no replication study has been conducted on this topic.Subjects and methodsWe increased 37 new patients and totally 234 patients were re-analyzed to further investigate the association of suicide-related behaviors with levels of trace lithium, EPA, DHA, and AA in a different way to avoid multicollinearity.ResultsHigher lithium levels were significantly associated with fewer suicide attempts and deliberate self-harm, higher EPA levels were significantly associated with fewer deliberate self-harm, and higher AA levels were significantly associated with more deliberate self-harm.DiscussionAlthough the sample size was only slightly larger than the previous study, the present results were clearly different from the previous ones due to the use of different statistical analyses to avoid multicollinearity.ConclusionThe present findings suggest that naturally absorbed lithium may protect against suicide and deliberate self-harm, while naturally absorbed EPA may protect against deliberate self-harm. However, naturally absorbed AA may be a risk factor for deliberate self-harm
IRAS 15099-5856: Remarkable Mid-Infrared Source with Prominent Crystalline Silicate Emission Embedded in the Supernova Remnant MSH15-52
We report new mid-infrared observations of the remarkable object IRAS
15099-5856 using the space telescopes AKARI and Spitzer, which demonstrate the
presence of prominent crystalline silicate emission in this bright source. IRAS
15099-5856 has a complex morphology with a bright central compact source (IRS1)
surrounded by knots, spurs, and several extended (~4') arc-like filaments. The
source is seen only at >= 10 um. The Spitzer MIR spectrum of IRS1 shows
prominent emission features from Mg-rich crystalline silicates, strong [Ne II]
12.81 um and several other faint ionic lines. We model the MIR spectrum as
thermal emission from dust and compare with the Herbig Be star HD 100546 and
the luminous blue variable R71, which show very similar MIR spectra. Molecular
line observations reveal two molecular clouds around the source, but no
associated dense molecular cores. We suggest that IRS1 is heated by UV
radiation from the adjacent O star Muzzio 10 and that its crystalline silicates
most likely originated in a mass outflow from the progenitor of the supernova
remnant (SNR) MSH 15-52. IRS1, which is embedded in the SNR, could have been
shielded from the SN blast wave if the progenitor was in a close binary system
with Muzzio 10. If MSH15-52 is a remnant of Type Ib/c supernova (SN Ib/c), as
has been previously proposed, this would confirm the binary model for SN Ib/c.
IRS1 and the associated structures may be the relics of massive star death, as
shaped by the supernova explosion, the pulsar wind and the intense ionizing
radiation of the embedded O star.Comment: 25 pages, 7 figures, Fig. 5 revised. Accepted for publication in Ap
Hepatitis B virus strains of subgenotype A2 with an identical sequence spreading rapidly from the capital region to all over Japan in patients with acute hepatitis B
ObjectiveTo examine recent trends of acute infection with hepatitis B virus (HBV) in Japan by nationwide surveillance and phylogenetic analyses.MethodsDuring 1991 through 2009, a sentinel surveillance was conducted in 28 national hospitals in a prospective cohort study. Genotypes of HBV were determined in 547 patients with acute hepatitis B. Nucleotide sequences in the preS1/S2/S gene of genotype A and B isolates were determined for phylogenetic analyses.ResultsHBV genotype A was detected in 137 (25% (accompanied by genotype G in one)) patients, B in 48 (9%), C in 359 (66%), and other genotypes in the remaining three (0.5%). HBV persisted in five with genotype A including the one accompanied by genotype G; another was co-infected with HIV type 1. The genotype was A in 4.8% of patients during 1991-1996, 29.3% during 1997-2002, and 50.0% during 2003-2008 in the capital region, as against 6.5%, 8.5% and 33.1%, respectively, in other regions. Of the 114 genotype A isolates, 13 (11.4%) were subgenotype A1, and 101 (88.6%) were A2, whereas of the 43 genotype B isolates, 10 (23.3%) were subgenotype B1, 28 (65.1%) were B2, two (4.7%) were B3, and three (7.0%) were B4. Sequences of 65 (64%) isolates of A2 were identical, as were three (23%) of A1, and five (18%) of B2, but none of the B1, B3 and B4 isolates shared a sequence.ConclusionsAcute infection with HBV of genotype A, subgenotype A2 in particular, appear to be increasing, mainly through sexual contact, and spreading from the capital region to other regions in Japan nationwide. Infection persisted in 4% of the patients with genotype A, and HBV strains with an identical sequence prevailed in subgenotype A2 infections. This study indicates the need for universal vaccination of young people to prevent increases in HBV infection in Japan
- …